New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone
摘要:
A series of 2(1H)-pyrrolidino [3,2-g]quinolinones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone, displayed moderate interaction with hAR, but more substituted analogues, particularly 6,7-disubstituted compounds, were potent hAR agonists in vitro. (C) 1998 Elsevier Science Ltd. All rights reserved.
Protease-activated receptor-1 (PAR-1) is a G-coupled receptor activated by alpha-thrombin and other proteases. In this paper we describe the synthesis and the pharmacological evaluation of novel peptide-mimetic antagonists (compounds 1-16) characterized by the presence of new heterocyclic nuclei such as 2-methyl-indole (5- and 6-substituted) and 1,4-benzodiazepine moiety. The new derivatives, tested in order to evaluate
v. Braun; Grabowski; Rawicz, Chemische Berichte, 1913, vol. 46, p. 3182
作者:v. Braun、Grabowski、Rawicz
DOI:——
日期:——
v. Braun, Chemische Berichte, 1914, vol. 47, p. 500
作者:v. Braun
DOI:——
日期:——
[EN] INHIBITORS OF KIF18A AND USES THEREOF<br/>[FR] INHIBITEURS DE KIF18A ET LEURS UTILISATIONS
申请人:[en]ACCENT THERAPEUTICS, INC.
公开号:WO2024035950A1
公开(公告)日:2024-02-15
Provided are compounds of the Formula (I), or pharmaceutically acceptable salts thereof, which are useful for the inhibition of KIF18A and in the treatment of a variety of KIF18A mediated conditions or diseases, such as cancer.
New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone
作者:James P. Edwards、Sarah J. West、Charlotte L.F. Pooley、Keith B. Marschke、Luc J. Farmer、Todd K. Jones
DOI:10.1016/s0960-894x(98)00107-3
日期:1998.4
A series of 2(1H)-pyrrolidino [3,2-g]quinolinones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone, displayed moderate interaction with hAR, but more substituted analogues, particularly 6,7-disubstituted compounds, were potent hAR agonists in vitro. (C) 1998 Elsevier Science Ltd. All rights reserved.